España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Mergers And Acquisitions
Deal Dispatch: Chicken Chains, Solar Pains And Disney's Hulu Gains — Plus, Why Big Tech Should Break Up
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta
Thoma Bravo Raises $34.4 Billion, Setting A Private-Equity Record: Report
Campbell's Brews Up Strong Q3: Beats Estimates As Home Cooking Sector Simmers
Thoma Bravo Raises $34.4 Billion, Setting A Private-Equity Record: Report
Campbell's Brews Up Strong Q3: Beats Estimates As Home Cooking Sector Simmers
Deal Dispatch: Beauty Brand Seeks Pretty Price Tag, Behavioral Health Firms Hit Auction Block
EOG Strikes $5.6B Deal To Expand Utica Footprint, Boosts Dividend
Read More...
Mergers And Acquisitions Recent News
Deal Dispatch: OnlyFans To Sell For $8 Billion? Telecom M&A Heats Up, Wolfspeed On Road To Bankruptcy
What's Next For Foot Locker? Analyst Says Dick's Deal Is Timely
The acquisition is a favorable outcome for Foot Locker shareholders, highlighting the 86% premium over the prior day's closing price.
Deal Dispatch: Starbucks Eyes China Sell-Off, Li-Cycle Powers Down, VCs Tackle 49ers Stake
Charter is acquiring Cox; VC titans are buying a 6% stake in a football franchise; and Dick's is buying Foot Locker in a $2.4 billion deal.
GSK To Buy Phase-3 Ready Liver Disease Drug For Up To $2 Billion
GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.
Deal Dispatch: Chef Boyardee, Crumbl Appear Tasty To Buyers While Bankruptcies Tick Upward
Cookie company Crumbl looks for dough while Forever 21 folds; the deal market was especially active this week.
Marriott Bets $355M On Trendy CitizenM Hotels To Woo Modern Travelers
Marriott International Inc. (NASDAQ: MAR) plans to acquire citizenM, a tech-savvy lifestyle hotel brand, for $355 million. The deal will add 36 hotels across major cities like New York, London, and Paris to Marriott's growing global portfolio.
Deal Dispatch: Jack In The Box To Dump Del Taco, Fyre Brand Hits Auction Block, Bertucci's Bites Bankruptcy Bullet (Again)
This week, deal pros have a lot to digest, including Bertucci's latest stumble plus Jack in the Box taking tacos to the auction block.
Walgreens Must Pay $300 Million In Opioid Case, Additional $50 Million If Sold Or Merged Before 2032
Walgreens settles with U.S. government for $300 million over allegations it filled unlawful opioid prescriptions.
Deal Dispatch: Metaverse Mergers, 23andMe Under Investigation, Burger King Franchise Goes Bankrupt
This week, TPG, Lyft, and GeneDX announced deals; Onsemi, meanwhile, ended discussions after offering its target $35.10 per share.
International Paper To Divest Five Box Plants In Europe, Seeks DS Smith Merger Approval
International Paper (IP) to sell 5 corrugated box plants in France, Portugal, and Spain to PALM Group, fulfilling regulatory obligation after DS Smith acquisition.
Deal Dispatch: Harley-Davidson To Wipe Out? Plus, Prada's Versace Purchase Garners A Fashionable Price
Things are hog wild at Harley-Davidson; Plus, Impresoft, Keros Therapeutics and Rivalry Corp. are all itching for a deal.
Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan
Keros Therapeutics launches strategic review and adopts rights plan after investor activity signals potential changes in company control.
KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover
KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into European healthcare.
Deal Dispatch: US M&A Is Quiet, But Abroad? Volume Is Spiking
BofA predicted a friendlier FTC under Trump. They were wrong. Deal activity was virtually flat in Q1. But it's a U.S. problem.
Deal Dispatch: Bezos-Backed Crop Company Wilts, Tech Startup Nabs Napster For $207 Million
AT&T, Searchlight Capital Partners, Blackstone, I Squared Capital, and Morgan Stanley are all actively seeking to ink a deal.
Deal Dispatch: Sandals For Sale, Chisholm's Celtic Pride, 'Matrix' Producer Faces Bankrupt Reality
This week's deal news column features Redwire, Sora Finance, Cylinder, Brookfield Asset Management and Nvidia.
Barnwell Sheds Hawaii Subsidiary To Refocus On Oil And Gas Ambitions
Barnwell Industries announces sale of subsidiary for $1.05 million, aligning with strategy to streamline operations and focus on oil and gas growth. CEO satisfied with team's execution.
Deal Dispatch: Trump M&A Boom Is A Bust, Purple Mattress Considers Sale, Celtics Auction Heats Up
Trump celebrated 50 days in office by claiming: "The winning never stops." But the losses are piling up across the deal landscape.
Warren Buffett's Real Estate Brokerage, Compass Discuss Deal: Report
Warren Buffett's real estate brokerage, HomeServices of America, is considering a deal with Compass, potentially consolidating the home-buying sector.
Rocket Wants $1.75 Billion Redfin Deal To Change How America Buys Homes
Redfin shareholders will receive 0.7926 shares of Rocket Class A common stock for each Redfin share—a 63% premium.
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's 2017 again.
Deal Dispatch: Boeing Done With Drones? Plus BP To Sell Lubricants, 7-Eleven Parent Nixes $58 Billion Bid
From Walgreens' breakup to Forever 21's pending bankruptcy, M&A and drama unfold in this week's edition of Deal Dispatch.
Deal Dispatch: NY Giants Look To Score Some Private Equity, Plus — M&A Volume Is Down
For all the 'deregulation is best-for-business' talk, deal pros don't have much to show for it: M&A is down compared to this time last year.